down arrow

Piramal Pharma

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE0DK501011
  • NSEID: PPLPHARMA
  • BSEID: 543635
INR
220.60
12.3 (5.9%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 54.01 lacs

Click here to access the older version
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Comparison
Company
Score
Quality
Valuation
Financial
Technical
Divi's Lab.
Suven Pharma
Cipla
Sun Pharma.Inds.
Wockhardt
Torrent Pharma
Gland Pharma
Piramal Pharma
Syngene Intl.
J B Chemicals &
Mankind Pharma
Why is Piramal Pharma Ltd ?
1
Low ability to service debt as the company has a high Debt to EBITDA ratio of 3.98 times
  • Low ability to service debt as the company has a high Debt to EBITDA ratio of 3.98 times
  • The company has been able to generate a Return on Equity (avg) of 0.48% signifying low profitability per unit of shareholders funds
2
Flat results in Dec 24
  • PAT(Q) At Rs 3.68 cr has Fallen at -80.6 %
3
Stock is technically in a Mildly Bearish range
  • The technical trend has deteriorated from Sideways on 04-Apr-25
  • Multiple factors for the stock are Bearish like MACD, Bollinger Band and KST
4
With ROCE of 4.8, it has a Expensive valuation with a 2.6 Enterprise value to Capital Employed
  • The stock is trading at a premium compared to its peers' average historical valuations
  • Over the past year, while the stock has generated a return of 52.38%, its profits have risen by 418.3% ; the PEG ratio of the company is 1.3
stock-recommendationReal-Time Research Report
Verdict Report
How much should you sell?
  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Drugs)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Piramal Pharma for you?

High Risk, High Return

Absolute
Risk Adjusted
Volatility
Piramal Pharma
52.14%
1.08
48.65%
SENSEX
0.45%
0.04
14.48%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
12.67%
EBIT Growth (5y)
505.10%
EBIT to Interest (avg)
0.74
Debt to EBITDA (avg)
5.61
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0.62
Tax Ratio
89.47%
Dividend Payout Ratio
81.66%
Pledged Shares
0
Institutional Holding
45.78%
ROCE (avg)
2.16%
ROE (avg)
0.48%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
526
Industry P/E
33
Price to Book Value
3.49
EV to EBIT
49.67
EV to EBITDA
22.63
EV to Capital Employed
2.60
EV to Sales
3.57
PEG Ratio
1.26
Dividend Yield
0.05%
ROCE (Latest)
4.76%
ROE (Latest)
0.96%
Loading Valuation Snapshot...
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Bearish (Daily)
KST
Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
No Trend
Bullish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
Analyse All Technical Factors stock-recommendation
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

0What is working for the Company
Icon
NO KEY POSITIVE TRIGGERS
-3What is not working for the Company
PAT(Q)

At Rs 3.68 cr has Fallen at -80.6 %

Loading Valuation Snapshot...
Here's what is not working for Piramal Pharma
Profit After Tax (PAT) - Quarterly
At Rs 3.68 cr has Fallen at -80.6 %
over average PAT of the previous four quarters of Rs 18.94 Cr
MOJO Watch
Near term PAT trend is very negative

PAT (Rs Cr)

Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."